The Uromigos Episode 4: Treatment Choices in Front Line Advanced Renal Cancer

Dr. Brian Rini and Professor Tom Powles ask Dr. David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab in treatment options. They also discuss the results of clinical trials on those two immunotherapy combinations.